AVEO - AVEO Pharmaceuticals Inc
Close
15
0 0%
Share volume: 0
Last Updated: Thu 19 Jan 2023 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$15.00
0.00
0.00%
Summary score
28%
Profitability
22%
Dept financing
38%
Liquidity
29%
Performance
32%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Sep-2018 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.07%
Return on assets
-10.87%
Return on sales
-486.13%
Return on invested capital
26.24%
Total debt ratio
75.96%
Debt ratio change over timeo
-2.93%
Current Ratio
3.57%
Quick Ratio
3.55%
Cash Position Ratio
3.21%
Short-term ratios 30-Sep-2021 - 30-Sep-2022
The data are presented for the financials results of the quarters of the last year.
Return on equity
-20.49%
Return on assets
-6.11%
Return on sales
-28.34%
Return on invested capital
31.54%
Total debt ratio
64.79%
Debt ratio change over timeo
2.59%
Current Ratio
3.97%
Quick Ratio
3.91%
Cash Position Ratio
3.21%
Last quarter ratios 30-Sep-2022
The data are presented for the financials results of the last quarter.
Return on equity
-11.32%
Return on assets
-2.14%
Return on sales
-7.12%
Return on invested capital
7.79%
Total debt ratio
71.51%
Debt ratio change over time
8.18%
Current Ratio
2.37%
Quick Ratio
2.35%
Cash Position Ratio
1.82%
Performance ratios (change over 4 years) 30-Sep-2018 - 30-Sep-2022
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
45.49%
Return on assets
-73.7%
Return on sales
-151.19%
Return on invested capital
215.07%
Total debt ratio
-293.35%
Debt ratio change over time
-2.93%
Current Ratio
5.18%
Quick Ratio
5.12%
Cash Position Ratio
4.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AVEO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -35.07% | 0% | 0% | -98.68% |
| Return on assets | -10.87% | 0% | 0% | -10.36% |
| Return on sales | -486.13% | 0% | 0% | -4130.66% |
| Return on invested capital | 26.24% | 0% | 0% | 39.41% |
| Profitability | 17% | 0% | 75% | 25% |
| Total debt ratio | 75.96% | 0% | 0% | 79.45% |
| Debt ratio change over time | -2.93% | 0% | 0% | -0.34% |
| Dept financing | 24% | 0% | 25% | 25% |
| Current Ratio | 3.97% | 0% | 0% | 10.69% |
| Quick Ratio | 3.91% | 0% | 0% | 10.69% |
| Cash Position Ratio | 3.21% | 0% | 0% | 10.53% |
| Liquididy | 34% | 0% | 0% | 75% |
| Short-term ratios | AVEO | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -20.49% | 0% | 0% | -490.06% |
| Return on assets | -6.11% | 0% | 0% | -10.34% |
| Return on sales | -28.34% | 0% | 0% | -9029.8% |
| Return on invested capital | 31.54% | 0% | 0% | -85.96% |
| Profitability | 25% | 0% | 75% | 0% |
| Total debt ratio | 64.79% | 0% | 0% | 86.06% |
| Debt ratio change over time | 2.59% | 0% | 0% | -2.02% |
| Dept financing | 44% | 0% | 0% | 25% |
| Current Ratio | 3.97% | 0% | 0% | 10.69% |
| Quick Ratio | 3.91% | 0% | 0% | 10.69% |
| Cash Position Ratio | 3.21% | 0% | 0% | 10.53% |
| Liquididy | 26% | 0% | 0% | 75% |